Skip NavigationSkip to Content

Panaxynol, a bioactive component of American ginseng, targets macrophages and suppresses colitis in mice

  1. Author:
    Chaparala, Anusha
    Poudyal, Deepak
    Tashkandi, Hossam
    Witalison, Erin E
    Chumanevich, Alexander A
    Hofseth, Jenna L
    Nguyen, Ivy
    Hardy, Olivia
    Pittman, Douglas L
    Wyatt, Michael D
    Windust, Anthony
    Murphy, Elizabeth A
    Nagarkatti, Mitzi
    Nagarkatti, Prakash
    Hofseth, Lorne J
  2. Author Address

    Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA., Laboratory of Human Retrovirology and Immunoinformatics, Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Department of Biological and Biomedical Sciences, Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Kannapolis, NC, USA., Measurement Science and Standards, National Research Council, Ottawa, ON, Canada., Department of Pathology, Microbiology, and Immunology, School of Medicine, University of South Carolina, Columbia, SC, USA.,
    1. Year: 2020
    2. Date: Jun 02
    3. Epub Date: 2020 06 02
  1. Journal: Oncotarget
    1. 11
    2. 22
    3. Pages: 2026-2036
  2. Type of Article: Article
  1. Abstract:

    Ulcerative colitis has a significant impact on the quality of life for the patients, and can substantially increase the risk of colon cancer in patients suffering long-term. Conventional treatments provide only modest relief paired with a high risk of side effects, while complementary and alternative medicines can offer safe and effective options. Over the past decade, we have shown that both American ginseng and its hexane fraction (HAG) have anti-oxidant and anti-inflammatory properties that can suppress mouse colitis and prevent colitis-associated colon cancer. With the goal of isolating a single active compound, we further fractionated HAG, and found the most abundant molecule in this fraction was the polyacetylene, panaxynol (PA). After isolating and characterizing PA, we tested the efficacy of PA in the treatment and prevention of colitis in mice and studied the mechanism of action. We demonstrate here that PA effectively treats colitis in a Dextran Sulfate Sodium mouse model by targeting macrophages for DNA damage and apoptosis. This study provides additional mechanistic evidence that American ginseng can be used for conventional treatment of colitis and other diseases associated with macrophage dysfunction.

    See More

External Sources

  1. DOI: 10.18632/oncotarget.27592
  2. PMID: 32547701
  3. PMCID: PMC7275787
  4. PII : 27592

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel